Clinical Trial Update: Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of an orally inhaled fluticasone furoate on growth velocity in prepubertal pediatric patients with asthma over o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone furoate (orally inhaled) (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2022-01-04